Raphael Mechoulam, Ph.D
Professor of Medicinal Chemistry and Natural Products
Hebrew University of Jerusalem, Israel
(Hebrew: רפאל משולם) (born 1930) is an Israeli professor of Medicinal Chemistry and Natural Products at the Hebrew University of Jerusalem in Israel. Mechoulam is best for his work (together with Y.
Gaoni) in the isolation, structure elucidation and total synthesis of Δ9-tetrahydrocannabinol, the main active principle of cannabis and for the isolation and the identification of the endogenous cannabinoids anandamide from the brain and 2-arachidonoyl glycerol (2-AG) from peripheral organs together with his students, postdocs and collaborators.
(Excerpt from http://en.wikipedia.org/wiki/Raphael_Mechoulam)
Robert Melamede, Ph.D
Associate Professor of Biology
University of Colorado, USA
Robert Melamede is an associate professor of biology at the University of Colorado, in one of the 11 states that allow the medicinal use of marijuana. Dr. Melamede is an expert on the biology of the cannabis plant, how it relates to the human endocannabinoid system, and why the cannabis plant has the potential to affect so many diseases and illnesses. Dr. Robert Melamede received his Ph.D. from the City University of New York. From there he became a Research Associate and Research Assistant Professor at New York Medical College. In 1989 he became a Research Assistant Professor at the University of Vermont. In 2001 he moved to the University of Colorado at Colorado Springs as an Associate Professor, and became the Chairman of the Biology Department until he retired as Chairman in the Fall of 2005.
Dr. Melamede's expertise has been the repair of DNA damages caused by free radicals, the production of monoclonal antibodies via phage display, far from equilibrium thermodynamics as applied to biological systems, and pulling these all together, the endocannabinoid system. Additional, Dr. Melamede is a founder of a small biotech company (Newellink) exploring novel cancer therapies.
Director of Clinical Research
McGill University Health Centre Pain Clinic,
Dr. Mark Ware was born in London, England in 1964 and raised in Jamaica. He trained in medicine at the University of the West Indies in Kingston, Jamaica, and after graduation in 1992 worked as a physician in London and Jamaica. While working with adult sickle cell patients in Jamaica, he became aware of the possibilities of cannabis use for pain management, and of the developing international interest in this field. This formed the basis for his MSc thesis in epidemiology at the London School of Hygiene and Tropical Medicine in 1999 and is his main research interest at present.
He is currently assistant professor in the departments of Anaesthesia and Family Medicine at McGill University. His clinical work is based at the MUHC Pain Centre where he sees patients with chronic pain. Dr. Ware lectures on design issues of clinical trials of complementary medicines to the McGill University Epidemiology and Biostatistics summer program. Dr. Ware is Scientific Director of the Canadian Consortium for the Investigation of Cannabinoids (CCIC), a network of investigators interested in working with the Medical Marijuana Research Programme and therapeutic cannabinoids. He is a member of the International Cannabinoid Research Society, the Canadian and International Pain Societies, and the Interdisciplinary Network for Complementary and Alternative Medicine Research (IN-CAM).His cannabis research has been published and presented at international conferences.
(Excerpt from http://www.themarknews.com/authors/1180-mark-ware)
Emeritus Professor of Medicine
Medical Director of the UCLA Pulmonary Function Laboratory,
Dr Donald Tashkin, M.D., (UCLA and U.S. government researcher) conducted the largest and longest study (30 years) on marijuana and its effects on the lungs when smoked. The hypothesis was that it would increase a person’s risk of lung cancer but actually found the opposite and that marijuana smoke actually provided some protection against lung cancer.
Associate Professor Emeritus of Psychiatry, Harvard Medical School,
Dr. Lester Grinspoon, a psychiatrist, is a retired professor at the Harvard Medical School and a well published author in the field of drugs and drug policy. He has authored more than 140 articles in scientific journals and twelve books, including Marijuana Reconsidered and Marijuana, The Forbidden Medicine.
Dr. Grinspoon is a frequent lecturer on drug policy issues and has appeared as an expert witness before legislative committees in several states and several committees of the U.S. Congress. In 1990 he received the Alfred R. Lindesmith Award for Achievement in the Field of Scholarship and Writing from the Drug Policy Foundation in Washington, DC.
Dr William Courtney, MD
Vice President of the Association Luxembourgeoise des Methodes Preventives
Dietary Raw Cannabis Specialist
Dr. William L. Courtney has an extensive medical education that began with a Bachelor of Science in Microbiology from the University of Michigan. He also received his Doctor of Medicine from Wayne State University, and Interned for Residency in Psychiatry at California Pacific Medical Center and went on to earned his Post Doctorate in Forensic Examination and Forensic Medicine. Dr. Courtney is currently a member of American Academy of Cannabinoid Medicine, the International Cannabinoid Research Society, the International Association of Cannabis as Medicine, and the Society of Clinical Cannabis. Dr. Courtney has also been teaching Continuing Medical Education (CME) courses in clinical cannabis.
His area of special interest is in the dietary uses of cannabis to achieve 250 to 500 mg of cannabinoid acids, which he considers as a conditionally essential nutrient in the diet of individuals from the 4th decade on. He has presented on high dose non-psychoactive dietary uses at Cannabis Therapeutics in Rhode Island April 2010, the Institute of Molecular Psychiatry at the University of Bonn in June 2010, the Institute for Advanced Studies at The Hebrew University of Jerusalem in November 2010, and the International Cannabinoid Research Society conference in Chicago in July 2011.
Dr. Courtney is Vice President of the Association Luxembourgeoise des Methodes Preventives, an ambulatory care facility in Luxembourg utilizing dietary unheated cannabis. He is working with dispensaries interested in providing high dose raw / juiced cannabis to seriously ill medical marijuana patients, and is also working to establish analytic / medical laboratories in Mendocino and Humboldt Counties, California.
operates to lend a helping hand to patients in
MMAR.ca is pleased to announce the re-opening of
Synergy Medicine. Dr. Price will be holding a weekly clinic in
Hamilton, Ontario to assess patients who feel they will benefit from medical Cannabis. Read more
"Derek Pedro has provided quality customer service, honest accounting, reliable pricing, quality products and promoted a positive customer relationship. I am pleased to recommend Derek Pedro as “your” designated grower."
K.P. - Ajax, ON